{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F56-novel-drug-development-part-1-alzheimers-disease-2020-BqFR_Cjo","width":444,"version":"1.0","type":"rich","title":"56 - Novel Drug Development Part 1: Alzheimer's Disease August 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/fde6d9c5-730a-41ab-9ee9-4da5b5c58ae9/56.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/270cdcca-6694-4ab3-a526-f50f54003ed4\" height=\"200\" width=\"100%\" title=\"56 - Novel Drug Development Part 1: Alzheimer&apos;s Disease August 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Marcia will tell you about papers published in August 2020 within the Novel drug development category that focus on all things Amyloid-beta. She will cover research focussed on targeting Amyloid-beta production, aggregation, and toxicity, as a way to combat AD."}